- December 15th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
A team of Princeton University scientists has produced a systematic listing of the ways a particular cancerous cell has “gone wrong,” giving researchers a powerful tool that eventually cou…
Read More »
- December 11th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
L’Oréal Paris Honors Women of Worth at Special Ceremony in New York City. Ten Women Recognized for Making a Difference in their Communities with Special Guests including Mary J. Blige, Holly Ro…
Read More »
- December 8th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. In the December 8 issue of Cancer Cell, the research team describes fin…
Read More »
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
“Cancer researchers at the University of Oklahoma Health Sciences Center have found a way to turn ineffective new cancer drugs into cancer-fighters. By using their patented chemical compound, SH…
Read More »
- December 7th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
MIT chemists have developed a new platinum compound that is as powerful as the commonly used anticancer drug cisplatin but better able to destroy tumor cells. Massachusetts Institute of Technology c…
Read More »
- November 22nd, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
One of the most comforting forms of support you can give a person with cancer is the use of touch. Family caregivers can significantly reduce symptoms in cancer patients at home through use of simple…
Read More »
- November 20th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
…[T]here are several PI3K signaling pathway targeting drugs in clinical development for use against ovarian cancer and solid tumors, including GDC-0941, BEZ235, SF1126, XL-147, XL-765, BGT226, a…
Read More »
- November 14th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Responding to a threat of a funding reduction to the Department of Defense’s Ovarian Cancer Research Program, during the last week of October the Ovarian Cancer National Alliance urged advocates to…
Read More »
- November 12th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Individuals who want to participate in research studies can connect online with researchers nationwide through the first disease-neutral, volunteer recruitment registry. ResearchMatch.org is a not-f…
Read More »
- November 11th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
The drug dasatinib (Sprycel®), approved for use by the U.S. Food and Drug Administration in patients with specific types of leukemia, significantly inhibited the growth and invasiveness of ovarian ca…
Read More »
- November 4th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Preliminary Phase II clinical study evaluation shows that primary efficacy endpoint has been met for patients with advanced-stage, platinum-resistant, taxane-pretreated ovarian cancer who were treated…
Read More »
- November 1st, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Drugs made using unusual metals could form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs, according to research at the…
Read More »
- October 23rd, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
As a result of a recent U.S. Senate mark-up, the funding for the Department of Defense Ovarian Cancer Research Program (DOD OCRP) has been slashed in half from $20 million to $10 million. Research co…
Read More »
- October 22nd, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Endocyte, Inc., … presented data from a Phase 2a clinical trial for EC145, … In 49 women with advanced-stage ovarian cancer, EC145 was shown to have anti-tumor activity in a significant p…
Read More »
- September 24th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Women with advanced ovarian cancer lived longer and without their tumors growing after receiving a modified regimen of a standard chemotherapy drug combination, Japanese researchers reported last week…
Read More »
- September 15th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
The U.S. Food and Drug Administration cleared a test that can help detect ovarian cancer in a pelvic mass that is already known to require surgery. The test, called OVA1, helps patients and health car…
Read More »
- September 1st, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Yesterday, U.S. President Barack Obama designated September 2009 as National Ovarian Cancer Awareness Month. National Ovarian Cancer Awareness Month helps educate women and men about the importance…
Read More »
- August 24th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
An Op-Ed entitled “To Fight Cancer, Know the Enemy” was published in The New York Times on August 6, 2009. The author of the Op-Ed was James D. Watson, Ph.D. James Watson co-discovere…
Read More »
- August 21st, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
University of Arizona researchers Jennifer Barton and Ray Kostuk have received a five-year, $2.4 million grant from the National Institutes of Health to build the instrument that they hope will one d…
Read More »
- August 19th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
NCCN [National Comprehensive Cancer Network] recently updated the NCCN Clinical Practice Guidelines in Oncology™ for the Prevention and Treatment of Cancer-Related Infections to include information…
Read More »
- August 14th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
The U.S. Food and Drug Administration (FDA) published two rules [on August 12, 2009] …that seek to clarify the methods available to seriously ill patients interested in gaining access to investi…
Read More »
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Many women at high risk for breast or ovarian cancer are choosing to undergo surgery as a precautionary measure to decrease their cancer risk, according to a report in Cancer Epidemiology, Biomarkers…
Read More »
- August 11th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
A new study finds that young women with early-stage ovarian cancer can preserve future fertility by keeping at least one ovary or the uterus without increasing the risk of dying from the disease. The…
Read More »
- August 10th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Two separate research teams reported promising results last week based upon preclinical studies involving the use of diphtheria toxin to fight ovarian cancer. … A targeted gene therapy was…
Read More »
- August 7th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Women who have premature menopause because of medical interventions are at an increased risk of developing lung cancer, according to a new study published in the International Journal of Cancer. The…
Read More »
- August 3rd, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Scientists have located a region of DNA which – when altered – can increase the risk of ovarian cancer according to research published in Nature Genetics today. An international research group le…
Read More »
- August 1st, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
A new study by Howard Hughes Medical Institute researchers shows that most early stage ovarian tumors exist for years at a size that is a thousand times smaller than existing tests can detect reliably…
Read More »
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
In a feat of trickery, Dartmouth Medical School immunologists have devised a Trojan horse to help overcome ovarian cancer, unleashing a surprise killer in the surroundings of a hard-to-treat tumor. U…
Read More »
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
With a novel therapeutic delivery system, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center has successfully targeted a protein that is over-expressed in ovaria…
Read More »
- July 28th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Vox Populi: Libby, We’ll Be Missing You. Dear Libby, One year ago today, you left us after an extended battle with ovarian cancer. You are missed as a wife, a daughter, a sister, an aunt an…
Read More »
- July 16th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Today, U.S. News & World Report issued its 2009-2010 rankings of the best U.S. hospitals for adults. The University of Texas, M.D. Anderson Cancer Center is rated #1 in cancer treatment; Brigham a…
Read More »
- June 18th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Today, Libby’s H*O*P*E*™ added a new widget to the homepage right sidebar. The widget, provided by SocialVibe.com, allows our sponsor, the TNT Network, to make donations to Stand Up To Cance…
Read More »
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
The 2009 American Society of Clinical Oncology (ASCO) Annual Meeting was held in Orlando, Florida from May 29 through June 2, 2009. We provide below select highlights from the 2009 ASCO Annual Meeti…
Read More »
- June 11th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
“… Vancouver scientists from the Ovarian Cancer Research (OvCaRe) Program at BC Cancer Agency and Vancouver Coastal Health Research Institute have discovered that there appears to be a sin…
Read More »
- June 5th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Every so often, you come across a story of hope, courage, and dogged perseverance that renews the spirit and lifts the soul. Gloria Johns’ story is a classic example. Gloria Johns is a 61 ye…
Read More »
- June 3rd, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Gene Network Sciences, Inc. (GNS) today announced that it has entered into a research collaboration with The University of Connecticut Health Center’s Carole and Ray Neag Comprehensive Cancer Ce…
Read More »
- May 31st, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Vox Populi*: A Daughter’s Thoughts On the 5th Anniversary of Her Mother’s Death From Ovarian Cancer Five Years. by Kia, Good Enough Mama weblog, February 8, 2009 Dear Mom, Today marks t…
Read More »
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
“European researchers report [at the 2009 American Society of Clinical Oncology Annual Meeting being held in Orlando, Florida from May 29 through June 2nd] that starting treatment early for an o…
Read More »
- May 29th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Stand Up To Cancer (SU2C), the Entertainment Industry Foundation’s charitable initiative supporting groundbreaking research aimed at getting new cancer treatments to patients in an accelerated t…
Read More »
- May 24th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
A women’s lifetime breast cancer risk is approximately 13 percent, and her ovarian cancer risk is less than 2 percent. But women with BRCA1 (BReast CAncer 1) or BRCA2 (BReast CAncer 2) gene mu…
Read More »
- May 21st, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
“Researchers in London have demonstrated the ability of adult stem cells from bone marrow (mesenchymal stem cells, or MSCs) to deliver a cancer-killing protein to tumors. The genetically engin…
Read More »
- May 18th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Researchers have generated altered immune cells that are able to shrink, and in some cases eradicate, large tumors in mice. The immune cells target mesothelin, a protein that is highly expressed, or t…
Read More »
- May 17th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Researchers from the Fred Hutchinson Cancer Research Center reported recently that symptoms of ovarian cancer tend to be relatively stable over time for women who are at increased risk of ovarian canc…
Read More »
- May 16th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
“People with cancer can reduce post-chemotherapy nausea by 40 percent by using ginger supplements, along with standard anti-vomiting drugs, before undergoing treatment, according to scientists a…
Read More »
- May 14th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
The 2009 Annual Meeting of the American Society of Clinical Oncology (ASCO) will be held in Orlando, Florida from May 29 through June 2, 2009. The ASCO Annual Meeting will be a forum for cutting-edge…
Read More »
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
On May 15, 2009, Craig Broeder Ph.D., FACSM, FNAASO will embark upon a 100-day bike trek that will take him to 32 U.S. cities as part of a 9,000 mile circumnavigation of the U.S. Since July 2008,…
Read More »
- May 13th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
“The American Civil Liberties Union and the Public Patent Foundation at Benjamin N. Cardozo School of Law (PUBPAT) filed a lawsuit … charging that patents on two human genes associated wit…
Read More »
- May 12th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
“The University of Pittsburgh Cancer Institute (UPCI) will be the primary site for a clinical trial of ABT-888, a drug previously proven in combination treatments to improve chemotherapy’s…
Read More »
- May 6th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
“… At Mother’s Day, a new survey from the National Ovarian Cancer Coalition (NOCC), www.ovarian.org, reveals some startling facts about women’s health: more than 52 percent of women ex…
Read More »
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
“… A pattern of genetic defects in tumours could indicate whether ovarian cancer patients will respond to common chemotherapy drugs before treatment starts, reveals a Cancer Research UK st…
Read More »